Levothyroxine Sodium Tablet
Product Images NDC 51655-846

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-846). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-846-52 (51655 846 52 Rev A 03 23)

Label for Levothyroxine Sodium Tablets, USP 25 mcg (0.025 mg), oral tablets by Northwind Pharmaceuticals, Indiana. The package contains 30 tablets with NDC 51655-846-52. The label includes storage instructions and manufacturer details.*

FDA Label Image

Levothyroixe Molecule (Levothyroxine Molecule)

Chemical structure of Levothyroxine Sodium showing two iodinated phenyl rings connected by an ether bond, with a side chain including an amino group, carboxylate group associated with sodium, and water of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.